The use of Ofatumumab in The Treatment of Multiple Sclerosis. Three Clinical Cases
DOI:
https://doi.org/10.61788/njn.v2i26.20Keywords:
multiple sclerosis, ofatumumab, oligoclonal antibodies, quality of lifeDownloads
Published
31.12.2024
How to Cite
Asadova, U., Shiraliyeva, R., & Qulieva А. (2024). The use of Ofatumumab in The Treatment of Multiple Sclerosis. Three Clinical Cases. National Journal of Neurology, 127–128. https://doi.org/10.61788/njn.v2i26.20
Issue
Section
Abstracts
License
Copyright (c) 2026 National Association of Neurologists

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



